Early detection of anthracycline- and trastuzumab-induced cardiotoxicity: value and optimal timing of serum biomarkers and echocardiographic parameters.
- DOI
- 10.1002/ehf2.13782
- Published
- 2022 Apr
- Container
- ESC heart failure
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/ehf2.13782,
title = {Early detection of anthracycline- and trastuzumab-induced cardiotoxicity: value and optimal timing of serum biomarkers and echocardiographic parameters.},
author = {Díaz-Antón B and Madurga R and Zorita B and Wasniewski S and Moreno-Arciniegas A and López-Melgar B and Ramírez Merino N and Martín-Asenjo R and Barrio P and Amado Escañuela MG and Solís J and Parra Jiménez FJ and Ciruelos E and Castellano JM and Fernández-Friera L},
year = {2022},
journal = {ESC heart failure},
doi = {10.1002/ehf2.13782},
url = {https://doi.org/10.1002/ehf2.13782}
}RIS
TY - JOUR TI - Early detection of anthracycline- and trastuzumab-induced cardiotoxicity: value and optimal timing of serum biomarkers and echocardiographic parameters. AU - Díaz-Antón B AU - Madurga R AU - Zorita B AU - Wasniewski S AU - Moreno-Arciniegas A AU - López-Melgar B AU - Ramírez Merino N AU - Martín-Asenjo R AU - Barrio P AU - Amado Escañuela MG AU - Solís J AU - Parra Jiménez FJ AU - Ciruelos E AU - Castellano JM AU - Fernández-Friera L PY - 2022 JO - ESC heart failure DO - 10.1002/ehf2.13782 UR - https://doi.org/10.1002/ehf2.13782 ER -
APA
B, D., R, M., B, Z., S, W., A, M., B, L., N, R. M., R, M., P, B., MG, A. E., J, S., FJ, P. J., E, C., JM, C., & L, F. (2022). Early detection of anthracycline- and trastuzumab-induced cardiotoxicity: value and optimal timing of serum biomarkers and echocardiographic parameters.. ESC heart failure. https://doi.org/10.1002/ehf2.13782
Source records
- pubmed · retrieved 2026-09-25T10:37:05.599Z